Description:
Tirzepatide is a novel drug developed by Eli Lilly and Company, primarily targeting the GIP (glucose dependent insulinotropic polypeptide) receptor and GLP
Contact Information
Location
9796, Baláže, Ernakulam
Phone
97961694
Email
liq134763@gmail.com
₹
9
More Listing
2.jpg)
.jpg)
2.jpg)
17.jpg)
10.jpg)